Alseres Pharmaceuticals Inc (ALSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2001 | 09-2001 | 06-2001 | 03-2001 | 12-2000 | |
| Operating Expenses | 2,289 | 2,733 | 3,124 | 2,440 | 2,070 |
| Operating Income | -2,289 | -2,733 | -3,124 | -2,440 | -2,070 |
| Other Income | -117 | 243 | -110 | 318 | 610 |
| Pre-tax Income | -2,406 | -2,490 | -3,234 | -2,122 | -1,460 |
| Net Income Continuous | -2,406 | -2,490 | -3,234 | -2,122 | -1,454 |
| Net Income | $-2,406 | $-2,490 | $-3,234 | $-2,122 | $-1,454 |
| EPS Basic Total Ops | -2,750.00 | -3,000.00 | -4,000.00 | -2,500.00 | -350.00 |
| EPS Basic Continuous Ops | -2,898.89 | -3,003.48 | -3,901.13 | -2,559.15 | -346.19 |
| EPS Diluted Total Ops | -2,750.00 | -3,000.00 | -4,000.00 | -2,500.00 | -350.00 |
| EPS Diluted Continuous Ops | -2,898.89 | -3,003.48 | -3,901.13 | -2,559.15 | -346.19 |
| EBITDA(a) | $-2,261 | $-2,719 | $-3,112 | $-2,434 | $-2,072 |